Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells.

Angiotensin II (AngII) induces G(1) phase arrest and hypertrophy of cultured renal proximal tubular cells. In previous studies, it was shown that these effects depend on oxygen radical-mediated induction of p27(Kip1), an inhibitor of cyclin-dependent kinases. The present study was undertaken to investigate whether mitogen-activated protein (MAP) kinases serve as signaling intermediates between AngII-induced oxidative stress and induction of p27(Kip1). AngII (10(-7) M) induces a biphasic phosphorylation pattern of p44/42 MAP kinase with an early phosphorylation after 2 min and a later, second phosphorylation peak after prolong incubation (12 h) in cultured proximal tubular cells from two different species (MCT and LLC-PK(1) cells). Total protein expression of MAP kinase was not changed by AngII. These phosphorylation patterns of p44/42 MAP kinase caused activation of the enzyme, as detected by phosphorylated MAP substrate Elk-1 after immuno-precipitation of MAP kinase. Exogenous H(2)O(2) also stimulates a biphasic phosphorylation of p44/42 MAP kinase. The flavoprotein inhibitor diphenylene iodinium, as well as the antioxidant N-acetylcysteine, prevented AngII-induced p44/42 MAP kinase phosphorylation, indicating involvement of reactive oxygen species generated by membrane-bound NAD(P)H oxidase. The MAP kinase kinase inhibitor PD98059 completely inhibits AngII-induced p27(Kip1) expression and (3)[H]leucine incorporation into proteins as a previously established marker of cell hypertrophy. PD98059 did not attenuate AngII-stimulated intracellular synthesis of oxygen radicals. Transient transfection with p44/42 MAP kinase antisense, but not sense, phosphorothioate-modified oligonucleotides also prevented AngII-induced MAP kinase phosphorylation, p27(Kip1) expression, and cell hypertrophy. Furthermore, induction of p27(Kip1) by H(2)O(2) was also abolished in the presence of PD98059. Although AngII induces phosphorylation of the stress-activated p38 MAP kinase, inhibition of this enzyme with SB203580 failed to attenuate induced p27(Kip1) expression and hypertrophy. These data provide evidence that AngII- mediated oxygen stress leads to the phosphorylation of p44/42 MAP kinase in proximal tubular cells. Activation of this enzyme is essential for p27(Kip1) expression, G(1) phase arrest, and hypertrophy of proximal tubular cells. These findings may lead to new concepts concerning interference of the development of proximal tubular hypertrophy, which may eventually turn into a maladaptive process in vivo leading ultimately to tubular atrophy and tubulointerstitial fibrosis.

[1]  Shokei Kim,et al.  Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. , 1999, Hypertension.

[2]  F. Boudreau,et al.  Attenuation of haptoglobin gene expression by TGFbeta requires the MAP kinase pathway. , 1999, Biochemical and biophysical research communications.

[3]  G. Ramponi,et al.  The Inactivation Mechanism of Low Molecular Weight Phosphotyrosine-protein Phosphatase by H2O2 * , 1998, The Journal of Biological Chemistry.

[4]  S. Nakashima,et al.  Possible Involvement of Mitogen‐Activated Protein Kinase in Phospholipase D Activation Induced by H2O2, but Not by Carbachol, in Rat Pheochromocytoma PC12 Cells , 1998, Journal of neurochemistry.

[5]  B. Brüne,et al.  Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition. , 1998, Journal of immunology.

[6]  Jiahuai Han,et al.  p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. , 1998, Circulation research.

[7]  M. Matsuzaki,et al.  Applied Pressure Enhances Cell Proliferation through Mitogen-activated Protein Kinase Activation in Mesangial Cells* , 1998, The Journal of Biological Chemistry.

[8]  J. Bonventre,et al.  Mitogen‐activated protein kinases and transcriptional responses in renal injury and repair , 1998, Current opinion in nephrology and hypertension.

[9]  M. Ushio-Fukai,et al.  Redox control of vascular smooth muscle proliferation. , 1998, The Journal of laboratory and clinical medicine.

[10]  P. Dent,et al.  The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. , 1998, The Biochemical journal.

[11]  E. Klann,et al.  Stimulation of p42 and p44 Mitogen‐Activated Protein Kinases by Reactive Oxygen Species and Nitric Oxide in Hippocampus , 1998, Journal of neurochemistry.

[12]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[13]  Bruno Amati,et al.  Phosphorylation‐dependent degradation of the cyclin‐dependent kinase inhibitor p27Kip1 , 1997, The EMBO journal.

[14]  G. Wolf,et al.  Angiotensin II inhibits inducible nitric oxide synthase in tubular MCT cells by a posttranscriptional mechanism. , 1997, Journal of the American Society of Nephrology : JASN.

[15]  M. Pagano,et al.  Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation , 1997, Leukemia.

[16]  K. Pumiglia,et al.  Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Wolf,et al.  Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1. , 1996, Kidney international.

[18]  A. Sorokin,et al.  Multiple intracellular MAP kinase signaling cascades. , 1996, Kidney international.

[19]  G. Wolf,et al.  Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. , 1996, Hypertension.

[20]  F. Marumo,et al.  Presence and regulation of Raf-1-K (Kinase), MAPK-K, MAP-K, and S6-K in rat nephron segments. , 1995, Journal of the American Society of Nephrology : JASN.

[21]  E. Krebs,et al.  Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells. , 1995, Kidney international.

[22]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[23]  B. Berk,et al.  Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. , 1995, Circulation research.

[24]  D. Fabbro,et al.  Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. , 1995, The Biochemical journal.

[25]  R. Harris.  Regulation of S6 kinase activity in renal proximal tubule. , 1992, The American journal of physiology.

[26]  G. Wolf,et al.  Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. , 1991, Kidney international.

[27]  G. Wolf,et al.  Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. , 1990, The American journal of physiology.

[28]  T. Haverty,et al.  Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis , 1988, The Journal of cell biology.

[29]  G. Wolf,et al.  Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. , 1998, Kidney international.

[30]  J. Bonventre,et al.  Growth factors and mitogen-activated protein kinases. , 1998, Hypertension.